Leading the Way in Cardiovascular Regenerative Medicine

Presented By:		Carl J. Pepine, MD, MACC, FESC Professor of Medicine Division of Cardiovascular Medicine University of Florida College of Medicine Gainesville, Florida Chairman, Vascular Biology Working Group

Program Description:	This CME activity consists of an educational component (ie, slides, audio lecture, newsletter) in an electronic format. Estimated time to complete this activity, including review of materials, is 1.5 hours.
General Information:	Requirements for Successful Completion: This CME activity consists of an educational component (ie, slides, audio lecture, newsletter) in an electronic format, which is followed by an online post-test. There is no fee to participate in this CME activity or to receive CME credit. Certificates are awarded upon successful completion (80% proficiency) of the post-test. In order to receive credit, participants must view the presentaion in its entirety. Media: Internet Release Date:    April 12, 2008 Expiration Date:  April 12, 2010
Target Audience:	Clinical and interventional cardiologists, and specialists in vascular biology research
Program Overview:	Despite refinements in conventional therapeutic approaches, mortality rates among individuals with refractory cardiovascular disease continue to be staggering, and physicians treating these patients must be prepared to add new—and sometimes controversial— therapeutic approaches to their armamentariums in order to improve patient care and promote patient survival. However, above all in a field as young and as rapidly changing as cell therapy, to make the leap from a promising theoretical concept to an effective therapeutic reality, it is paramount that physicians be supported in their efforts by ready access the latest information and most pertinent findings in cell-based therapies and clinical applications. An initiative at the forefront of this exciting and rapidly evolving field, the VBWG educational program on cell therapy will meet this need by supplying information on state-of-the-art therapeutic options for optimizing treatment and survival in patients with refractory CVD. Topics covered include types of cells used, how therapy is delivered, results of recent studies in regenerative medicine, and what the future holds for cell therapy research.
Learning Objectives:	1. Understand both the validity and importance of cell regeneration as a potential therapeutic modality in patients with refractory or end-stage CVD, including individuals with acute MI, ischemic cardiomyopathy, chronic myocardial ischemia, or intractable angina 2. Review and critically examine both preclinical and early-stage clinical research data on cell therapy-based cardiac regeneration and repair, along with the clinical implications of these findings 3. Develop familiarity with the full range of cell therapy options for clinical application, including the cell types used, indications for use, and results observed to date 4. Evaluate cell therapy treatment options for individual cardiac patients in reference to therapeutic cell type, delivery mode, and delivery timing
Faculty Disclosure:	The University of Florida College of Medicine has a conflict of interest policy that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they simply are noted here to fully inform participants.
Continuing Medical Education Credit:
	Accreditation
	The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
	Credit
	The University of Florida College of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
	This continuing education activity was planned in accordance with the ACCME essentials and reviewed by Carl J. Pepine, MD, Program Chair.
	Click here for disclosure and disclaimer information
Commercial Support:	This CME activity is supported by an educational grant from Baxter Healthcare Corporation.
System Requirements:	In order to view the presentation, your computer must have a media player such as Windows Media Player, Quicktime, or RealOne.
CME Contact:	For any question regarding this Internet CME activity, please contact the Office of Continuing Medical Education at 352-265-8081.
	The University of Florida College of Medicine has received permission to use this copyrighted material within a CME activity on the internet.

Take this presentation with you:
Download this Online Lecture as an MP3 and load it onto your iPod or other portable audio player.
MP3 Audio File
(Right-click and select "Save Target As..." to download)